RE
BIVV

RBC Europe’s Bioverativ Inc. Common Stock BIVV Stock Holding History

RBC Europe’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-741
Closed -$40K – 1191
2017
Q4 		$40K Buy
741
+24
+3% +$1.31K ﹤0.01% 528
2017
Q3 		$40.9K Buy
+717
New +$42K 0.01% 524

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

RBC Europe's BIVV Position: Q1 2018 in Review

RBC Europe sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 741 shares — an estimated $40K sold.

RBC Europe first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $40.9K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • RBC Europe reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • RBC Europe sold 741 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $40K.
  • RBC Europe first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • RBC Europe's Bioverativ Inc. Common Stock position peaked at $40.9K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on RBC Europe's 13F filing for Q1 2018, filed 9 Nov 2023.